Statement Of Cash Flows [Abstract]

Xspray Pharma - Filing #702828

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
55 983 SEK
46 477 SEK
Adjustments for decrease (increase) in trade and other receivables
5 712 SEK
2 479 SEK
Adjustments for increase (decrease) in trade and other payables
10 087 SEK
3 794 SEK
Cash flows from (used in) investing activities [abstract]
Payments for development project expenditure
94 651 SEK
88 983 SEK
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
29,000 SEK
188,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.